| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 16 |
| 1 | PREDNISOLONE ORAL | 16 |
| 2 | PREDNISOLONE ORAL SOLUTION | 16 |
| 3 | PREDNISONE | 12 |
| 4 | RITUXIMAB | 12 |
| 5 | TACROLIMUS | 11 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 11 |
| 7 | TACROLIMUS OINTMENT 0.1% | 11 |
| 8 | CYCLOSPORINE | 10 |
| 9 | CYCLOPHOSPHAMIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AVACOPAN | 5 | 0.0007 |
| 1 | LETERMOVIR | 1 | 0.0003 |
| 2 | GANCICLOVIR SODIUM | 3 | 0.0003 |
| 3 | CHLORAMBUCIL | 1 | 0.0003 |
| 4 | MANNITOL | 1 | 0.0002 |
| 5 | BUSULFAN | 2 | 0.0001 |
| 6 | FLUDARABINE PHOSPHATE | 5 | 0.0001 |
| 7 | METHYLPREDNISOLONE ACETATE | 1 | 0.0001 |
| 8 | EVEROLIMUS TABLETS | 2 | 0.0001 |
| 9 | DASPONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Complement 5a Receptor Antagonist [EPC] | 5 | 0.0007 |
| 2 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 3 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 7 | Sulfone [EPC] | 1 | 0.0001 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 10 | 0.0001 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |